Friday, May 29, 2015

ASCO: Immunotherapy Ups Survival in Non-Small Cell Lung CA

(MedPage Today) -- In comparison with standard chemotherapy, efficacy is higher and toxicity is lower
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)